Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
U.S. FDA Approves Pfizer's RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease
04:45pm, Tuesday, 22'nd Oct 2024
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory Syncytial Virus Vaccine), the company's bivalent
Is Pfizer's Attractive Valuation Enough to Invest in the Stock?
04:01pm, Tuesday, 22'nd Oct 2024
PFE's non-COVID drugs and potential contributions from new and newly acquired products have started to drive growth.
Activist Investor Starboard Slams Pfizer for Underperforming R&D And Overpaying for Acquisitions
01:55pm, Tuesday, 22'nd Oct 2024
Activist investor Starboard Value has sharpened its criticism of Pfizer Inc. PFE, holding the pharmaceutical giant's management accountable for failing to deliver on its promises of innovation and gro
Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises
12:04pm, Tuesday, 22'nd Oct 2024
Starboard took aim at Pfizer in another blow Tuesday, saying the company has failed to deliver on what it called the "best pipeline" ever.
Activist hedge fund Starboard met with Pfizer last week. Here's what went down.
11:06am, Tuesday, 22'nd Oct 2024
Activist hedge fund Starboard has taken a stake in drug giant Pfizer. Starboard execs met with company officials last week to outline their complaints.
Pfizer (PFE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Tuesday, 22'nd Oct 2024
Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Starboard Value CEO Jeff Smith: Pfizer needs to do a better job disciplining itself on investments
10:48am, Tuesday, 22'nd Oct 2024
Jeff Smith, Starboard Value CEO, joins CNBC's 'Squawk on the Street' to discuss how he sees Pfizer going forward, potential for growth in Kenvue, and more.
Do Billionaires Israel Englander and Ken Griffin Know Something? Each Just Bought This Plagued Value Stock.
10:15am, Tuesday, 22'nd Oct 2024
Hedge funds managed by Israel Englander and Ken Griffin both scooped up shares in a troubled pharmaceutical stock last quarter.
2 Deeply Discounted Ultra-High-Yield Dividend Stocks to Buy Right Now
09:45am, Tuesday, 22'nd Oct 2024
Investing in the stock market has long proven itself as a winning formula for generating wealth, though there are many paths to profits.
5 Large Drug Stocks Likely to Outpace Q3 Earnings Estimates
09:35am, Tuesday, 22'nd Oct 2024
Let us look at some big drug/biotech stocks, NVO, NVS, PFE, REGN and BIIB, which are poised to beat on third-quarter earnings.
Starboard Makes Its Case to Shake-Up Pfizer and Kenvue
09:18am, Tuesday, 22'nd Oct 2024
Starboard has a $1 billion stake in Pfizer and an unknown but "sizable" stake in Kenvue, according to earlier media reports.
Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to Note
06:51pm, Monday, 21'st Oct 2024
Pfizer (PFE) reachead $28.93 at the closing of the latest trading day, reflecting a -0.99% change compared to its last close.
1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
05:49am, Monday, 21'st Oct 2024
Income investors have both good and not-so-good options in the healthcare sector.
Pfizer: Activists Clouding A Promising Picture
08:00pm, Sunday, 20'th Oct 2024
Pfizer's deep valuation and large dividend yield make it an attractive investment, despite potential distractions from activist investors. The focus should remain on existing cost realignment plans an
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
07:30am, Saturday, 19'th Oct 2024
Yes, bargains can still be found in the stock market.
